01

ABBVIE

U.S.A

Antibody Engineering

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2031-03-02

LEVOMILNACIPRAN HYDROCHLORIDE

US Patent Number : 8481598

Drug Substance Claim :

Drug Product Claim :

Application Number : 204168

Patent Use Code : U-839

Patent Use Description : TREATMENT OF MAJOR DEP...

Patent Expiration Date : 2031-03-02

Product Web Link

Corporate PDF

02

ABBVIE

U.S.A

Antibody Engineering

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2026-01-11

LEVOMILNACIPRAN HYDROCHLORIDE

US Patent Number : RE43879

Drug Substance Claim :

Drug Product Claim :

Application Number : 204168

Patent Use Code : U-839

Patent Use Description : TREATMENT OF MAJOR DEP...

Patent Expiration Date : 2026-01-11

Product Web Link

Corporate PDF

03

ABBVIE

U.S.A

Antibody Engineering

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2031-03-02

LEVOMILNACIPRAN HYDROCHLORIDE

US Patent Number : 8481598

Drug Substance Claim :

Drug Product Claim :

Application Number : 204168

Patent Use Code : U-839

Patent Use Description : TREATMENT OF MAJOR DEP...

Patent Expiration Date : 2031-03-02

Product Web Link

Corporate PDF

04

ABBVIE

U.S.A

Antibody Engineering

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2031-03-02

LEVOMILNACIPRAN HYDROCHLORIDE

US Patent Number : 8481598

Drug Substance Claim :

Drug Product Claim :

Application Number : 204168

Patent Use Code : U-839

Patent Use Description : TREATMENT OF MAJOR DEP...

Patent Expiration Date : 2031-03-02

Product Web Link

Corporate PDF

05

ABBVIE

U.S.A

Antibody Engineering

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2026-01-11

LEVOMILNACIPRAN HYDROCHLORIDE

US Patent Number : RE43879

Drug Substance Claim :

Drug Product Claim :

Application Number : 204168

Patent Use Code : U-839

Patent Use Description : TREATMENT OF MAJOR DEP...

Patent Expiration Date : 2026-01-11

Product Web Link

Corporate PDF

06

ABBVIE

U.S.A

Antibody Engineering

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2026-01-11

LEVOMILNACIPRAN HYDROCHLORIDE

US Patent Number : RE43879

Drug Substance Claim :

Drug Product Claim :

Application Number : 204168

Patent Use Code : U-839

Patent Use Description : TREATMENT OF MAJOR DEP...

Patent Expiration Date : 2026-01-11

Product Web Link

Corporate PDF

07

ABBVIE

U.S.A

Antibody Engineering

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2026-01-11

LEVOMILNACIPRAN HYDROCHLORIDE

US Patent Number : RE43879

Drug Substance Claim :

Drug Product Claim :

Application Number : 204168

Patent Use Code : U-839

Patent Use Description : TREATMENT OF MAJOR DEP...

Patent Expiration Date : 2026-01-11

Product Web Link

Corporate PDF

08

ABBVIE

U.S.A

Antibody Engineering

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2031-03-02

LEVOMILNACIPRAN HYDROCHLORIDE

US Patent Number : 8481598

Drug Substance Claim :

Drug Product Claim :

Application Number : 204168

Patent Use Code : U-839

Patent Use Description : TREATMENT OF MAJOR DEP...

Patent Expiration Date : 2031-03-02

Product Web Link

Corporate PDF

09

ABBVIE

U.S.A

Antibody Engineering

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2032-05-23

LEVOMILNACIPRAN HYDROCHLORIDE

US Patent Number : 8865937

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 204168

Patent Use Code :

Patent Use Description :

Patent Expiration Date : 2032-05-23

Product Web Link

Corporate PDF

10

ABBVIE

U.S.A

Antibody Engineering

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2032-05-23

LEVOMILNACIPRAN HYDROCHLORIDE

US Patent Number : 8865937

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 204168

Patent Use Code :

Patent Use Description :

Patent Expiration Date : 2032-05-23

Product Web Link

Corporate PDF

Milnacipran HCl

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

16 API Suppliers

10 USDMF

4 EU WC

7 NDC API

12 Listed Suppliers

FINISHED DOSAGE FORMULATIONS

25 FDF Dossiers

20 FDA Orange Book

4 Canada

1 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CAPSULE, EXTENDED RELEASE;ORAL - EQ 120MG BASE

CAPSULE, EXTENDED RELEASE;ORAL - EQ 20MG BASE

CAPSULE, EXTENDED RELEASE;ORAL - EQ 40MG BASE

CAPSULE, EXTENDED RELEASE;ORAL - EQ 80MG BASE

RELATED EXCIPIENT COMPANIES

3 DKSH

1 Faran Shimi Pharmaceutical

1 Boai NKY Pharmaceuticals Ltd

2 Gangwal Healthcare

1 Nanjing Well Pharmaceutical

1 Pfanstiehl

1 ACG Worldwide

1 Actylis

1 Aeon Procare

1 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

9 BASF

11 Corel Pharma Chem

4 Gangwal Chemicals

4 Ideal Cures Pvt Ltd

12 Kerry

4 Kima Chemical

6 Lonza Capsugel

2 Microlex e.U

2 Novo Excipients

1 Pharmatrans-Sanaq

1 Pluviaendo

1 Qianhao Chemical (Hebei) Co., Ltd

1 Qualicaps

2 Roquette

7 Seppic

1 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

1 Sigachi Industries

3 The Dow Chemical Company

1 Vertellus

EXCIPIENTS BY APPLICATIONS

47 Coating Systems & Additives

24 Controlled & Modified Release

13 Fillers, Diluents & Binders

12 Film Formers & Plasticizers

9 Granulation

7 Solubilizers

6 Taste Masking

6 Direct Compression

5 Coloring Agents

5 Empty Capsules

4 Vegetarian Capsules

4 Thickeners and Stabilizers

3 API Stability Enhancers

3 Parenteral

2 Lubricants & Glidants

2 Co-Processed Excipients

2 Disintegrants & Superdisintegrants

1 Surfactant & Foaming Agents

1 Emulsifying Agents

1 Rheology Modifiers

1 Chewable & Orodispersible Aids

DIGITAL CONTENT

1 DATA COMPILATION #PharmaFlow

5 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions

4 Finished Drug Prices

4 Annual Reports